|
Notice to our subscribers currently receiving printed copies of our magazine: Due to COVID-19, we are delivering each issue to you via email. Please note your issues will also still be delivered to you via postal mail, and will be awaiting your return to the office. If you wish to change your delivery address, or delivery preference, you can do so via our online subscription form.
|
| |
|
|
|
|
|
|
TOP STORIES
Updates on COVID-19 vaccine candidates, FDA policies, company partnerships, and more.
/ read more /
|
|
Through the agreement, BARDA will support the advancement of the vaccine candidate to FDA licensure and will handle all late-stage clinical development programs, as well as the scale-up of mRNA-1273 manufacture in 2020.
/ read more /
|
|
| |
|
SubscribeSubscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.
subscription offers
|
|
|
Industry News
Experts to discuss strategies for ensuring supply of quality drug products during a pandemic in April 28 online event.
/ read more /
A report into the Swiss biotech sector has shown that there is continued growth in the sector, which has received investments from public and private companies worth CHF 1.2 billion (US$1.2 billion).
/ read more /
MORE INDUSTRY NEWS
|
| |
|
Biopharma News
A UK BioIndustry Association industry-led vaccine manufacturing group has welcomed a recent announcement by the government of the UK, that it will receive £14 million (US$17.3 million) in investment to rapidly scale up the development of vaccines for COVID-19.
/ read more /
MicrofluidX has raised £1.4 million (US$1.7 million) in seed funding, which it will use to develop its novel cell bioprocessing technology for cell and gene therapy.
/ read more /
More Biopharma News
|
| |
|
Supplier News
Suppliers to the bio/pharma industry are sharing news about the business operations during the global COVID-19 pandemic. To view current information about the company’s business operations, click the company name.
/ read more /
|
|
Bayer will provide CAD $1.5 million (USD$1 million) toward two studies to evaluate its chloroquine and interferon beta-1b combination therapies.
/ read more /
More Supplier News
|
|
Regulatory News
The approval was based off of positive results from a Phase III study that showed patients 70 years or younger treated with the BTK inhibitor lived longer without disease progression.
/ read more /
|
With hundreds of clinical trials for potential coronavirus therapies in the works concerns have mounted about the emergence of conflicting data, useless results, and wasted efforts from multiple overlapping efforts.
/ read more /
More Regulatory News
|
|
FEATURED TOPICS |
|
FORMULATION
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.
/ read more /
|
|
|
|
|
QUALITY SYSTEMS
Risk assessments, audits, and good communication between sponsor and supplier are key elements of supplier oversight.
/ read more /
|
|
|
|
|
BIOBUSINESS
As politicians focus on drug cost reduction, biopharmaceutical companies in the US are moving to states with lower taxes and relocating some facilities that had been offshore.
/ read more /
|
|
|
|
WEBCASTS
Implementing Attribute Monitoring Analyses for Biopharmaceutical Development and QC
Wednesday, April 29, 2020, 9am EDT| 2pm BST| 3pm CEST
Learn More
Practical Method Development Strategies for the Analysis of Monoclonal Antibodies by Reversed-Phase HPLC
Thursday, May 21, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More
Vaccines Illuminated: Biophysical Characterization, PAT, and Quality Control via Light-Scattering Techniques
Tuesday, May 19, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Learn More
Ensuring the Continuous Supply of Quality Drug Products During Uncertain Times
Tuesday, April 28, 2020, 11 am EDT | 10 am CDT | 8 am PDT
Learn More
Accurate Weighing of Reference Standards in a QC Laboratory
Thursday, May 28, 2020 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST
Learn More
|
Rescheduled Events
CPhI South East Asia has been rescheduled for July 2020.
Interphex 2020 has been rescheduled for July 2020.
PDA’s Annual Meeting has been rescheduled for July 2020.
Bioprocessing Summit Europe has been rescheduled for July 2020.
PDA’s Pharmaceutical Manufacturing Data Science Workshop has been rescheduled for July 2020.
CPhI North America has been rescheduled for September 2020.
CPhI Japan has been rescheduled for September 2020.
Analytica 2020 has been rescheduled for October 2020.
Interpack 2020 has been rescheduled for February 2021.
more events
|
|
|
eBook
|
The Pharmacopoeia Compliance Series features a description of ways biopharma companies can participate in monograph development, a case study of a practical approach to pharmacopoeial compliance, and a summary of this 12-part series.
|
|
|
|
| |
